Cell therapy Omisirge receives FDA approval for blood cancer patients
The US Food and Drug Administration (FDA) has approved Gamida Cell’s allogeneic cell therapy, Omisirge (omidubicel-onlv), for blood cancer patients.
Source: biopharma-reporter.com